FDA Approvals

Date Posted
Article Title
8/4/2009
FDA Approves Avastin for Most Common Kidney Cancer

In combination with a second drug

8/4/2009
Livalo Approved for High Cholesterol

A risk factor for heart disease

8/3/2009
Sustained-Release Antipsychotic Approved for Schizophrenia

Invega Sustenna injected once monthly

7/31/2009
Onglyza Sanctioned for Type 2 Diabetes

A once-daily tablet to help control blood sugar

7/31/2009
Colcrys Approved for Acute Gout, Mediterranean Fever

Remedy long used to treat these two inflammatory conditions

7/24/2009
Forteo Approved for Drug-Related Osteoporosis

For people taking glucocorticoid medications

7/20/2009
Seasonal Flu Vaccine Approved

But it won't protect against swine flu

7/16/2009
Onsolis Approved for Severe Cancer Pain

Due to abuse risks, patch will be available under restricted distribution

7/10/2009
Effient Sanctioned for Angioplasty Patients

To reduce the risk of blood clots

7/6/2009
7/2/2009
Multaq Sanctioned for Heart Rhythm Disorders

Atrial fibrillation or atrial flutter

6/18/2009
Ozurdex Implant Approved for Macular Edema

When cause is blocked vein, doctors have a new therapy to offer

6/12/2009
Caldolor Is First Approved Injected Ibuprofen

For hospital patients who can't take oral drug

6/3/2009
New Drug Fights Cancer in Dogs

Palladia approved to treat dangerous skin tumors

5/29/2009
Besivance Approved for Bacterial Conjunctivitis

Contagious condition often called 'pink eye'

5/28/2009
Ankle Replacement Device Approved

For people with deformed or arthritic joint

5/26/2009
Adcirca Approved for Lung Disorder

Drug has the same active ingredient as Cialis

5/18/2009
Risperdal Consta Approved for Bipolar Disorder

Long-acting version of antipsychotic

5/14/2009
Cimzia Approved for Rheumatoid Arthritis

Previously sanctioned for Crohn's disease

5/7/2009